PRIMO 2017
Register Now

2017 Practical Recommendations in Immuno and Molecular Oncology Conference

The Practical Recommendations in Immuno and Molecular Oncology (PRIMO) Meetings are unique opportunities to receive CME credits while staying ahead of the latest advances in immuno and molecular oncology.

The 2017 Annual PRIMO Meeting is designed to summarize key developments in cancer care over the past 12 months, and feature expected advances that you and your patients will likely see in the upcoming year.

2016 PRIMO Regional Meetings focus on recent advances specific to hematology. There are currently four regional PRIMO meetings available in different US regions — register for FREE today to earn credits before the end of 2016.


Agenda

The 2017 Annual PRIMO Meeting agenda has been carefully tailored to meet the educational needs of all attendees, with an emphasis on the following key areas:

Practical considerations of applying biomarkers and targeted therapy
Integration of immunotherapy, with a focus on novel management approaches
Patient selection, as well as timing and sequencing of therapy
Dealing with important trends, such a big data and defining value in cancer care

Faculty

An elite faculty is currently being assembled for the 2017 Annual PRIMO Meeting by our expert Steering Committee, led by our Co-Chairs Dr. Brahmer and Dr. Vose.

Co-Chairs

Julie Brahmer, MD

Associate Professor of Oncology
Director, Thoracic Professor of Oncology
Sidney Kimmel Comprehensive
Cancer Center
Johns Hopkins Medicine
Baltimore, Maryland

Julie M. Vose, MD, MBA

Neumann M. and Mildred E.
Harris Professor
Chief Division of Hematology/ Oncology
Professor of Medicine
Nebraska Medical Center
Omaha, Nebraska

Steering Committee

Sanjiv S. Agarwala, MD

Professor of Medicine
Chief Oncology & Hematology
St. Luke’s University Hospital and
Temple University
Philadelphia, PA

Charles M. Balch, MD FACS

Research Professor of Surgery
University of Texas
MD Anderson Cancer Center,
Houston Texas
Editor-in-Chief, Annals of Surgical Oncology

Sagar Lonial, MD

Professor
Department of Hematology
and Medical Oncology
Chief Medical Officer
Winship Cancer Institute
Emory University
Atlanta, Georgia

Hope S. Rugo, MD

Professor of Medicine
Director, Breast Oncology
and Clinical Trials Education
UCSF Helen Diller Family
Comprehensive Cancer Center
San Francisco, California

Faculty

Leora Horn, MD, MSc

Associate Professor of Medicine
Clinical Director
Thoracic Oncology Program
Vanderbilt University
Ingram Cancer Center
Nashville, Tennessee

Hagop M. Kantarjian

Professor and Chairman
Department of Leukemia
Samsung Distinguished University
Chair in Cancer Medicine
University of Texas
MD Anderson Cancer Center
Dallas, Texas

Gilberto de Lima Lopes Jr., MD, MBA, FAMS

Assitant Professor of Oncology
Johns Hopkins University
Baltimore, Maryland
Chief Medical and Scientific Officer
Oncoclinicas Group
Sao Paulo, Brazil

Shane Y. Morita

Director
Surgical Oncology Program
The Queen’s Medical Center
Honolulu, Hawaii

Suresh Ramalingam, MD

Professor of Hematology and
Medical Oncology
Director of Medical Oncology
Winship Cancer Institute
of Emory University
Atlanta, Georgia

Alan P. Venook, MD

Professor of Medical Oncology
Chief, Gastrointestinal Oncology
UCSF Helen Diller Family
Comprehensive Cancer Center
San Francisco, California

Exhibitors and Sponsors

The PRIMO Meetings offer a fantastic opportunity for industry leaders to interact with leading multidisciplinary oncologists, and stay up to date with the latest information regarding targeted and immunologic therapies.